Friday, October 30, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

NCT07850063 · PHASE3 · NOT YET RECRUITING · Sponsor: Boehringer Ingelheim · Conditions: Obesity, Metabolic Dysfunction-associated Steatotic Liver

PR
By Priya Raman · Science Reporter
Oct 30 08:00 ETSource: ClinicalTrials.gov

From the source

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

NCT07850063 · PHASE3 · NOT YET RECRUITING · Sponsor: Boehringer Ingelheim · Conditions: Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →